The importance of sexuality, changes in erectile functioning and its association with self-esteem in men with localized prostate cancer: data from an observational study.
Active surveillance
Erectile functioning
Importance of sexuality
Localized prostate cancer
Radical prostatectomy
Self-esteem
Journal
BMC urology
ISSN: 1471-2490
Titre abrégé: BMC Urol
Pays: England
ID NLM: 100968571
Informations de publication
Date de publication:
21 Jan 2019
21 Jan 2019
Historique:
received:
01
06
2018
accepted:
09
01
2019
entrez:
23
1
2019
pubmed:
23
1
2019
medline:
9
5
2019
Statut:
epublish
Résumé
Treatment for localized prostate cancer (PCa) can cause long-term changes in erectile functioning. However, data on the importance of sexuality and possible consequences of altered erectile functioning on self-esteem in men with localized PCa are lacking. Self-report questionnaires were completed by 292 men with PCa, initially managed with active surveillance (AS) or radical prostatectomy (RP). Independent t-tests were conducted to evaluate group differences. A sequential multiple regression model was fitted to analyze the associations between the importance of sexuality, changes in erectile functioning and impairment of self-esteem. Interaction effects were tested using simple slope analyses. Participants were 70 ± 7.2 years old and 66.5% rated sex as being "rather/very important". The two groups differed markedly in changes in erectile functioning, importance of sexuality and impairment of self-esteem (p < .001), with higher values in RP patients. Regression analysis showed that after adjustment for control variables and importance of sexuality, changes in erectile functioning were still associated with impairment of self-esteem (B = .668, SE = .069, p < .001). The interaction of changes in erectile functioning and importance of sexuality reached significance (B = .318, SE = .062, p < .001). RP patients report more changes in erectile functioning than AS patients. Moreover, in men with localized PCa, erectile functioning and self-esteem are closely related. Sexuality seems to be important for the majority of these men. Physicians should address the possibility of erectile dysfunction and its potential effects on psychological well-being before the treatment decision.
Sections du résumé
BACKGROUND
BACKGROUND
Treatment for localized prostate cancer (PCa) can cause long-term changes in erectile functioning. However, data on the importance of sexuality and possible consequences of altered erectile functioning on self-esteem in men with localized PCa are lacking.
METHODS
METHODS
Self-report questionnaires were completed by 292 men with PCa, initially managed with active surveillance (AS) or radical prostatectomy (RP). Independent t-tests were conducted to evaluate group differences. A sequential multiple regression model was fitted to analyze the associations between the importance of sexuality, changes in erectile functioning and impairment of self-esteem. Interaction effects were tested using simple slope analyses.
RESULTS
RESULTS
Participants were 70 ± 7.2 years old and 66.5% rated sex as being "rather/very important". The two groups differed markedly in changes in erectile functioning, importance of sexuality and impairment of self-esteem (p < .001), with higher values in RP patients. Regression analysis showed that after adjustment for control variables and importance of sexuality, changes in erectile functioning were still associated with impairment of self-esteem (B = .668, SE = .069, p < .001). The interaction of changes in erectile functioning and importance of sexuality reached significance (B = .318, SE = .062, p < .001).
CONCLUSIONS
CONCLUSIONS
RP patients report more changes in erectile functioning than AS patients. Moreover, in men with localized PCa, erectile functioning and self-esteem are closely related. Sexuality seems to be important for the majority of these men. Physicians should address the possibility of erectile dysfunction and its potential effects on psychological well-being before the treatment decision.
Identifiants
pubmed: 30665424
doi: 10.1186/s12894-019-0436-x
pii: 10.1186/s12894-019-0436-x
pmc: PMC6341743
doi:
Types de publication
Journal Article
Multicenter Study
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
9Subventions
Organisme : Stiftung Oskar-Helene-Heim
ID : AZ-17
Références
Int J Impot Res. 2000 Dec;12(6):305-11
pubmed: 11416833
Cancer. 2002 Jul 15;95(2):281-6
pubmed: 12124827
N Engl J Med. 2002 Sep 12;347(11):790-6
pubmed: 12226149
Geriatr Nurs. 2005 May-Jun;26(3):166-75
pubmed: 15973345
J Sex Res. 2005 May;42(2):138-49
pubmed: 16123844
J Sex Med. 2007 Jan;4(1):83-92
pubmed: 17233777
J Sex Med. 2007 Mar;4(2):448-64
pubmed: 17367440
J Urol. 2007 Sep;178(3 Pt 1):826-31; discussion 831-2
pubmed: 17632144
Ann Intern Med. 2008 Mar 18;148(6):435-48
pubmed: 18252677
Qual Health Res. 2009 Apr;19(4):432-43
pubmed: 19229061
Aging Male. 2010 Dec;13(4):258-64
pubmed: 21067475
Lancet Oncol. 2011 Sep;12(9):891-9
pubmed: 21821474
Ann Intern Med. 2011 Dec 6;155(11):762-71
pubmed: 21984740
BJU Int. 2012 Oct;110(7):1032-9
pubmed: 22260273
J Sex Med. 2012 Oct;9(10):2724-32
pubmed: 22989267
Best Pract Res Clin Endocrinol Metab. 2013 Aug;27(4):581-601
pubmed: 24054932
Intern Med J. 2014 Jan;44(1):18-26
pubmed: 24450519
J Sex Med. 2015 Feb;12(2):494-504
pubmed: 25358901
Eur Urol. 2015 Apr;67(4):637-45
pubmed: 25454617
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29
pubmed: 25559415
Urol Int. 2015;95(2):209-15
pubmed: 26044747
Int J Cancer. 2016 Aug 15;139(4):749-53
pubmed: 27038059
Urologe A. 2016 Oct;55(10):1321-1328
pubmed: 27138634
Support Care Cancer. 2016 Oct;24(10):4309-17
pubmed: 27220648
N Engl J Med. 2016 Oct 13;375(15):1425-1437
pubmed: 27626365
Transl Androl Urol. 2017 Feb;6(1):60-68
pubmed: 28217451